Retinal degeneration 3 (RD3) protein promotes accumulation of retinal membrane guanylyl cyclase (RetGC) in the photoreceptor outer segment and suppresses RetGC activation by guanylyl cyclase-activating proteins (GCAPs). Mutations truncating RD3 cause severe congenital blindness by preventing the inhibitory binding of RD3 to the cyclase. The high propensity of RD3 to aggregate in solution has prevented structural analysis. Here, we produced a highly soluble variant of human RD3 (residues 18-160) that is monomeric and can still bind and negatively regulate RetGC. The NMR solution structure of RD3 revealed an elongated backbone structure (70 A long and 30 A wide) consisting of a four-helix bundle with a long unstructured loop between helices 1 and 2. The structure reveals that RD3 residues previously implicated in the RetGC binding map to a localized and contiguous area on the structure, involving a loop between helices 2 and 3 and adjacent parts of helices 3 and 4. The NMR structure of RD3 was validated by mutagenesis. Introducing Trp(85) or Phe(29) to replace Cys or Leu, respectively, disrupts packing in the hydrophobic core and lowers RD3's apparent affinity for RetGC1. Introducing a positive charge at the interface (Glu(32) to Lys) also lowered the affinity. Conversely, introducing Val in place of Cys(93) stabilized the hydrophobic core and increased the RD3 affinity for the cyclase. The NMR structure of RD3 presented here provides a structural basis for elucidating RD3-RetGC interactions relevant for normal vision or blindness.
Retinal degeneration 3 (RD3) protein, a retinal guanylyl cyclase regulator, forms a monomeric and elongated four-helix bundle
Creators
Igor V. Peshenko - Salus University
Qinhong Yu - University of California, Davis
Sunghyuk Lim - University of California, Davis
Diana Cudia - University of California, Davis
Alexander M. Dizhoor - Salus University
James B. Ames - University of California, Davis
Publication Details
The Journal of biological chemistry, v 294(7), pp 2318-2328
Publisher
Amer Soc Biochemistry Molecular Biology Inc
Number of pages
11
Grant note
R01EY011522 / NATIONAL EYE INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)
EY11522; EY012347 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
Pennsylvania Department of Health CURE Formula grant
Resource Type
Journal article
Language
English
Academic Unit
Neurobiology and Anatomy; Pennsylvania College of Optometry (PCO)
Web of Science ID
WOS:000458895400010
Scopus ID
2-s2.0-85061575985
Other Identifier
991022035111704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: